It is not required to delay the administration of ART after CM is diagnosed; however, it may be prudent to wait four to eight weeks after antifungal therapy is started before beginning ART to avoid immune reconstitution inflammatory syndrome (IRIS), especially in patients with a low initial CD4 count. This evidence concerns the gene CD4 and cutaneous mastocytosis.